OpenAlex
PricingAboutJobs
Log inGet started
Author

Lipeng Xue

Institutions: First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health
Observed institutions: First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University Cancer Hospital, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health
ORCID: 0009-0006-4693-4396
Observed ORCID: 0009-0006-4693-4396
OpenAlex ID: A5100584819
Revealing underlying regulatory mechanisms of LINC00313 in Osimertinib-resistant LUAD cells by ceRNA network analysis
2024 · Dandan Ding, Chenguang Xu, et al. · Translational Oncology · 12
Efficacy and safety of immune checkpoint inhibitors in lung cancer patients with hepatitis B surface antigen positivity: a real-world cohort study
2026 · Xiaohuan Zhou, Yi Feng, et al. · Lung Cancer · 1
First-line treatment for unresectable pulmonary lymphoepithelial carcinoma: A real-world comparison of platinum-based doublet chemotherapy with or without PD-1 inhibitors
2026 · Lipeng Xue, Yi Feng, et al. · Lung Cancer
Works count: 3
Citation count: 13
H-index: 1
I10-index: 1
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security